Inovio Pharmaceuticals (FRA:GBM) Current Accrued Expense : €6.66 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Inovio Pharmaceuticals Current Accrued Expense?

Inovio Pharmaceuticals's Current Accrued Expense for the quarter that ended in Mar. 2024 was €6.66 Mil.

Inovio Pharmaceuticals's quarterly Current Accrued Expense increased from Sep. 2023 (€6.71 Mil) to Dec. 2023 (€8.07 Mil) but then declined from Dec. 2023 (€8.07 Mil) to Mar. 2024 (€6.66 Mil).

Inovio Pharmaceuticals's annual Current Accrued Expense increased from Dec. 2021 (€12.77 Mil) to Dec. 2022 (€54.60 Mil) but then declined from Dec. 2022 (€54.60 Mil) to Dec. 2023 (€8.07 Mil).

Inovio Pharmaceuticals Current Accrued Expense Historical Data

The historical data trend for Inovio Pharmaceuticals's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inovio Pharmaceuticals Current Accrued Expense Chart

Inovio Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

5.76

14.14

12.77

54.60

8.07

Inovio Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															10.97	8.09	6.71	8.07	6.66

Inovio Pharmaceuticals Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Inovio Pharmaceuticals Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Inovio Pharmaceuticals's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Inovio Pharmaceuticals (FRA:GBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (FRA:GBM) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

INO:USA INO:Mexico

Address

660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462

Website

https://www.inovio.com

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals (FRA:GBM) Headlines

No Headlines